Zogenix, Inc. (ZGNX)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
9.15+0.27 (+3.04%)
As of 10:05 AM EDT. Market open.
People also watch:
GALESNTASGYPAVEOCPRX
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open8.88
Prev Close8.88
Bid9.02 x 200
Ask9.07 x 400
Day's Range8.83 - 9.15
52wk Range7.33 - 21.03
1y Target EstN/A
Market Cap226.84M
P/E Ratio (ttm)-4.21
Beta1.58
Volume14,928
Avg Vol (3m)151,585
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Capital Cube10 days ago

    ETF’s with exposure to Zogenix, Inc. : August 15, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Zogenix, Inc. Here are 5 ETF’s with the largest exposure to ZGNX-US. Comparing the performance and risk of Zogenix, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Zogenix, Inc. :ZGNX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016
    Capital Cube13 days ago

    Zogenix, Inc. :ZGNX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016

    Categories: Yahoo Finance Click here to see latest analysis Zogenix, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of Zogenix, Inc. – DURECT Corporation, Mallinckrodt Plc, Merck & Co., Inc., Antares Pharma, Inc., Nektar Therapeutics, Johnson & Johnson, Cardinal Health, Inc., Eli Lilly and Company, Alkermes ... Read more (Read more...)

  • 24/7 Wall St.13 days ago

    Why This Analyst Sees Huge Upside for Valeant and 2 More Specialty Pharmas

    All three of these specialty pharmaceutical stocks come with a fair share of risk but provide big upside potential as well.